Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2024.1394702
Abstract: The Kirsten rat sarcoma viral oncoprotein homolog (KRAS) is currently a primary focus of oncologists and translational scientists, driven by exciting results with KRAS-targeted therapies for non-small cell lung cancer (NSCLC) patients. While KRAS mutations… read more here.
Keywords: cancer; perspectives recent; recent breakthrough; breakthrough efforts ... See more keywords